Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound E Jiao Jiang for anemia in mid-to-late pregnancy
ChiCTR2300078484Phase 4Recruiting
- Sponsor
- Peking University Third Hospital
- Start
- Nov 2023
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Implantable Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Fufang E'jiao Jiang and ferrous succinate in iron deficiency anemia (IDA) (2 arms), sponsored by Peking University Third Hospital. Primary endpoint: Hemoglobin. Started Nov 2023; status: recruiting.
02
Drugs
Fufang E'jiao Jiangferrous succinate
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on ChiCTR2300078484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078484.